8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549
                              --------------------


                                    FORM 8-K

                                 CURRENT REPORT
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

Date of report (Date of earliest event reported):  June 3, 2004
                                                   ------------

                             THE QUIGLEY CORPORATION
                             -----------------------
               (Exact Name of Registrant as Specified in Charter)

      NEVADA                            01-21617             23-2577138
(State or Other Jurisdiction            (Commission          (IRS Employer
of Incorporation)                       File Number)         Identification No.)

   Kells Building, 621 Shady Retreat Road, P.O. Box 1349, Doylestown, PA 18901
   ---------------------------------------------------------------------------
               (Address of Principal Executive Offices)              (Zip Code)


Registrant's telephone number, including area code: (215) 345-0919
                                                    --------------

                                       N/A
                                       ---
         (Former Name or Former Address, if Changed Since Last Report.)








Item 5.     Other Events and Required FD Disclosure.
            ----------------------------------------

            On June 3, 2004, The Quigley  Corporation  (the "Company")  issued a
press  release  providing  an  update  on  its  proposed   distribution  to  its
stockholders  of shares of common stock of Suncoast  Naturals,  Inc. held by the
Company. The full text of the press release is attached hereto as Exhibit 99.1.

Item 7.     Financial Statements, Pro Forma Financial Information and Exhibits.
            ------------------------------------------------------------------

(c)         Exhibits

            Exhibit No.           Description
            -----------           -----------

            99.1                  Press Release dated June 3, 2004







                                   SIGNATURES

            Pursuant to the requirements of the Securities Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.



Dated:  June 4, 2004                 THE QUIGLEY CORPORATION



                                     By: /s/ George J. Longo
                                         -----------------------
                                     Name:  George J. Longo
                                     Title: Vice President and
                                            Chief Financial Officer

EX-99.1

                                                                    EXHIBIT 99.1

                                    QUIGLEY

Contact:
David K. Waldman/John W. Heilshorn                       Carl Fonash
Lippert Heilshorn & Associates                           The Quigley Corporation
(212) 838-3777                                           (267) 880-1111
dwaldman@lhai.com


        THE QUIGLEY CORPORATION PROVIDES AN UPDATE OF ITS PROPOSED STOCK
         DIVIDEND OF SHARES OF COMMON STOCK OF SUNCOAST NATURALS, INC.


DOYLESTOWN, PA. - JUNE 3, 2004 - THE QUIGLEY CORPORATION (NASDAQ: QGLY) by press
release dated February 19, 2003,  announced a distribution  of 500,000 shares of
common stock of Suncoast Naturals Inc., held in The Quigley  Corporation's name,
to stockholders of record on March 6, 2003. The distribution was made contingent
upon the filing of a  registration  statement  covering these shares by Suncoast
Naturals,  Inc. and it being declared effective.  The registration  statement is
not yet effective,  and thus, The Quigley  Corporation will be required to set a
new record date and notify its  stockholders  once the  Securities  and Exchange
Commission declares the registration statement effective.

ABOUT THE QUIGLEY CORPORATION

The Quigley Corporation (Nasdaq:  QGLY,  http://www.Quigleyco.com)  is a leading
developer and marketer of diversified health products including the COLD-EEZE(R)
family of patented zinc  gluconate  glycine  (ZIGG(TM))  lozenges and sugar free
tablets. COLD-EEZE is the only (ZIGG) lozenge proven in two double-blind studies
to reduce the  duration  of the common  cold from 7.6 to 4.4 days or by 42%.  In
addition to  Over-The-Counter  (OTC)  products,  the Company has formed  Quigley
Pharma   Inc.   (http://www.QuigleyPharma.com   ),  a   wholly   owned   ethical
pharmaceutical  subsidiary,  to introduce a line of  naturally-derived  patented
prescription drugs. The Quigley Corporation's customers include leading national
wholesalers  and  distributors,  as well as independent and chain food, drug and
mass  merchandise  stores  and  pharmacies.  The  Quigley  Corporation  makes no
representation  that  the  U.S.  Food  and  Drug  Administration  or  any  other
regulatory  agency  will  grant an IND or take any  other  action  to allow  the
aforementioned products to be studied or marketed. Furthermore, no claim is made
that the potential  medicine discussed here is safe,  effective,  or approved by
the Food and Drug Administration.

Certain statements in this press release are "forward-looking statements" within
the meaning of the Private Securities  Litigation Reform Act of 1995 and involve
known and  unknown  risk,  uncertainties  and other  factors  that may cause the
company's actual performance or achievements to be materially different from the
results, performance or achievements expressed or implied by the forward-looking
statement.  Factors that impact such forward-looking  statements include,  among
others,  changes in worldwide general economic  conditions,  changes in interest
rates, government regulations, and worldwide competition.